| 11713299 |
Histone methyltransferase inhibitors |
Zhe Li |
2023-08-01 |
|
| 11661410 |
Tricyclic compounds as histone methyltransferase inhibitors |
Zhe Li, Qing Xu, Manuel Zancanella |
2023-05-30 |
|
| 11584734 |
Tricyclic compounds as histone methyltransferase inhibitors |
Zhe Li, Qing Xu, Calvin W. Yee, Lina Q. Setti, Hing L. Sham |
2023-02-21 |
|
| 11566030 |
Substituted 2,6-dihydropyrrolo[3,4-c]pyrazoles as pyruvate kinase activators |
Lina Q. Setti, Shahul Nilar, Zhe Li, Manuel Zancanella |
2023-01-31 |
|
| 11306107 |
Compounds that inhibit MCL-1 protein |
Sean P. Brown, David Karl Bedke, Michael R. DeGraffenreid, Jiasheng Fu, Zhihong Li +23 more |
2022-04-19 |
$184,680,000 |
| 11254651 |
Histone methyltransferase inhibitors |
Zhe Li, Lina Q. Setti |
2022-02-22 |
$27,987,000 |
| 11111243 |
Azaindole compounds as histone methyltransferase inhibitors |
Chul Yu, Manuel Zancanella, Zhe Li |
2021-09-07 |
$29,337,000 |
| 11014884 |
Modulators of hemoglobin |
Brian W. Metcalf, Zhe Li, Qing Xu, Kobina N. Dufu, James Partridge +1 more |
2021-05-25 |
$34,874,000 |
| 10836779 |
Compounds that inhibit MCL-1 protein |
Sean P. Brown, Yunxiao Li, Mike Lizarzaburu, Brian S. Lucas, Nick A. Paras +7 more |
2020-11-17 |
$427,887,000 |
| 10829510 |
Method for preparing sucralose-6-acetate in biphasic liquid-liquid system |
Fuxiang Deng, Yu Ding, Wei Xue, Sheng Yu, Wenwu Yan +2 more |
2020-11-10 |
|
| 10829452 |
Histone methyltransferase inhibitors |
Zhe Li |
2020-11-10 |
$19,064,000 |
| 10826017 |
Packaging assembly and preparation method thereof, and display device |
— |
2020-11-03 |
|
| 10144746 |
Bridged bicyclic kallikrein inhibitors |
Zhe Li, Manuel Zancanella, Chul Yu, Lina Q. Setti, Hing L. Sham +2 more |
2018-12-04 |
$46,677,000 |
| 10100063 |
Compounds that inhibit Mcl-1 protein |
Sean P. Brown, Yunxiao Li, Mike Lizarzaburu, Brian S. Lucas, Nick A. Paras +7 more |
2018-10-16 |
$127,891,000 |
| 10065901 |
Method for preparing optically active carbonyl compound |
Yougui Zhou, Jintao Yuan, Lei Zhao, Xiandong Zhu, Guangxiong Yu +8 more |
2018-09-04 |
|
| 10058849 |
Metal complex catalyst, preparation method thereof, and use thereof in preparing D,L-menthol |
Jintao Yuan, Haidong Yu, Weikang Shao, Yuhong Zhang |
2018-08-28 |
|
| 9815853 |
Bridged bicyclic kallikrein inhibitors |
Zhe Li, Manuel Zancanella, Chul Yu, Lina Q. Setti, Hing L. Sham +2 more |
2017-11-14 |
$26,621,000 |
| 9593129 |
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer |
Michael D. Bartberger, Ana Z. Gonzalez Buenrostro, Hilary Plake Beck, Xiaoqi Chen, Richard V. Connors +36 more |
2017-03-14 |
$585,925,000 |
| 9296736 |
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer |
Michael D. Bartberger, Ana Z. Gonzalez Buenrostro, Hilary Plake Beck, Xiaoqi Chen, Richard V. Connors +36 more |
2016-03-29 |
$89,902,000 |
| 8785468 |
Phenylalanine amide derivatives useful for treating insulin-related diseases and conditions |
Xiaohui Du, Zice Fu, Jonathan Houze, XianYun Jiao, Yong-Jae Kim +6 more |
2014-07-22 |
$478,714,000 |
| 8748462 |
Spirocyclic GPR40 modulators |
Sean P. Brown, Paul John Dransfield, Xiaohui Du, Zice Fu, Jonathan Houze +12 more |
2014-06-10 |
$235,140,000 |
| 8680129 |
Compounds, composition, methods, targets for cancer therapy |
— |
2014-03-25 |
|
| 8450522 |
Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders |
Sean P. Brown, Paul John Dransfield, Jonathan Houze, Todd J. Kohn, Jiwen Liu +6 more |
2013-05-28 |
$360,303,000 |
| 8030354 |
Substituted biphenyl GPR40 modulators |
Sean P. Brown, Qiong Cao, Paul John Dransfield, Xiaohui Du, Zice Fu +22 more |
2011-10-04 |
$40,772,000 |
| 8022061 |
N-aryl pyrazole compounds, compositions, and methods for their use |
Yasuyuki Ogawa, Ryo Okuyama, Satoshi Shibuya, Narihiro Toda, Zhaodan Cao +7 more |
2011-09-20 |
$86,603,000 |
